LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement.

Samanci, Cesur / Saylan, Bengu / Gulsen, Gokce / Akkaya, Yuksel / Yesildal, Melike / Akkaya Isik, Sinem / Ustabasioglu, Fethi Emre

Clinical and experimental hypertension (New York, N.Y. : 1993)

2021  Volume 43, Issue 4, Page(s) 341–348

Abstract: ... ACEIs)/angiotensin receptor blockers (ARBs) on lung involvement in patients with COVID-19 pneumonia and ... hypertension (HT). Our aim was to compare the lung involvement of the HT patients hospitalized for COVID-19 ... a diagnosis of HT among the patients treated for laboratory-confirmed COVID-19 between 31 March 2020 and 28 ...

Abstract Objective: There is not enough data on the effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on lung involvement in patients with COVID-19 pneumonia and hypertension (HT). Our aim was to compare the lung involvement of the HT patients hospitalized for COVID-19 using ACEIs/ARBs with the patients taking other anti-HT medications.
Methods: : Patients who have a diagnosis of HT among the patients treated for laboratory-confirmed COVID-19 between 31 March 2020 and 28 May 2020 were included in the study. One hundred and twenty-four patients were divided into two as ACEIs/ARBs group (n = 75) and non-ACEIs/ARBs group (n = 49) according to the anti-HT drug used. The chest CT involvement areas of these two groups were evaluated quantitatively by two observers including all lobes, and total severity score (TSS) was calculated. These TSS values were compared between drug groups and clinical groups.
Results: In clinical classification; there were 4 (%3.2) asymptomatic, 5 (4.0%) mild type, 92 (74.1%) common type, 14 (11.3%) severe type, 9 (7.3%) critical type patients. ACEI/ARB group's TSS (mean±SD, 7.74 ± 3.54) was statistically higher than other anti-HT medication group (mean±SD, 4.40 ± 1.89) (
Conclusions: Quantitative evaluation of CT and TSS score can give an idea about the clinical classification of the patient. TSS is higher in ACEI/ARB group than non-ACEIs/ARBs group.
MeSH term(s) Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/physiopathology ; Correlation of Data ; Female ; Humans ; Hypertension/drug therapy ; Hypertension/epidemiology ; Lung/diagnostic imaging ; Lung/physiopathology ; Lung/virology ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Tomography, X-Ray Computed/methods ; Tomography, X-Ray Computed/statistics & numerical data ; Turkey/epidemiology
Chemical Substances Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors
Language English
Publishing date 2021-02-13
Publishing country England
Document type Journal Article
ZDB-ID 604757-9
ISSN 1525-6006 ; 0730-0077
ISSN (online) 1525-6006
ISSN 0730-0077
DOI 10.1080/10641963.2021.1883051
Shelf mark
Zs.A 1429: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top